drugset / Trial / NCT07037654

Lingual Ondansetron in Reduction of Spinal Hypotension in Cesarean Section

NCT07037654

Active not recruiting 112 enrolled Suez Canal University
RandomizedParallel-groupDouble-blindPrevention

Summary

The goal of this clinical trial is to learn if drug ondansetron, used in lingual form, lowers the incidence of spinal anesthesia-induced hypotension in cesarean sections. It will also learn about the safety of drug ondansetron. The main questions it aims to answer are Does the drug ondansetron, used in lingual form, lower the incidence of spinal anesthesia-induced hypotension in cesarean sections? What medical problems do participants have when taking the drug ondansetron? Researchers will compare drug ondansetron to a placebo (a look-alike substance that contains no drug) to see if drug ondansetron works to reduce the incidence of spinal anesthesia-induced hypotension in cesarean sections Participants will: Take drug ondansetron or a placebo before induction of spinal anesthesia

Timeline

Start
2025-06-01
Primary completion
2026-07-01
Completion
2026-09-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ondansetron Other / unclassified 8 mg Other

Indications

No indication recorded.